SpringWorks Therapeutics Announces PDUFA Date Extension for Nirogacestat NDA

1 year ago

by David Miller

949 Views

Written by David Miller

FDA Extending PDUFA Date by Three Months to Allow More Time to Complete Their Review New PDUFA Date Set to November 27, 2023 STAMFORD, Conn., June 05, 2023 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!